These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6182012)

  • 21. Action of probenecid on the central nervous system of the rabbit. II. Potentiation of 5-hydroxytryptophan-induced hyperthermia and suppression of this effect by a decarboxylase inhibitor (Ro4-4602).
    Gardey-Levassort C; Olive G; Lechat P
    Pharmacology; 1974; 11(5):267-77. PubMed ID: 4546714
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased brain serotonergic activity after acute propranolol.
    Giarcovich S; Enero MA
    Eur J Pharmacol; 1984 Apr; 100(1):123-5. PubMed ID: 6609828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenfluramine and brain serotonin.
    Clineschmidt BV; Zacchei AG; Totaro JA; Pflueger AB; McGuffin JC; Wishousky TI
    Ann N Y Acad Sci; 1978 Jun; 305():222-41. PubMed ID: 309298
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ipsapirone on the level of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in some regions of the rat brain.
    GoĊ‚embiowska K
    Pol J Pharmacol Pharm; 1989; 41(1):33-9. PubMed ID: 2479937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man.
    van Praag HM; Korf J; van Woudenberg F
    Psychopharmacologia; 1970; 18(4):412-20. PubMed ID: 4923523
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional differences in the response of serotonergic neurons in rat CNS to drugs.
    Long JB; Youngblood WY; Kizer JS
    Eur J Pharmacol; 1983 Mar; 88(1):89-97. PubMed ID: 6602057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats.
    Crandall EA; Gillis MA; Fernstrom JD
    Endocrinology; 1981 Jul; 109(1):310-2. PubMed ID: 6165572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced alterations in the efflux of 5-hydroxytryptamine and of 5-hydroxyindoleacetic acid into superfusates of the rat spinal cord.
    Hammond DL; Tyce GM; Yaksh TL
    Eur J Pharmacol; 1983 Mar; 87(4):441-8. PubMed ID: 6189730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The origin of blood 5-hydroxyindoleacetic acid following L-hydrazine-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The origin of blood k-hydroxyindoleacetic acid following L-hydrazino-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of blood ingestion on brain serotonin synthesis in portacaval-shunted rats.
    Bartelmess P; Bengtsson F; Nobin A; Jeppsson B; Herlin P; Bugge M
    Res Exp Med (Berl); 1987; 187(5):353-8. PubMed ID: 2448852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of leucine on brain serotonin.
    Ramanamurthy PS; Srikantia SG
    J Neurochem; 1970 Jan; 17(1):27-32. PubMed ID: 5312858
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
    Gehrke BJ; Harrod SB; Cass WA; Bardo MT
    Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    Fuller RW; Snoddy HD; Molloy BB
    J Pharmacol Exp Ther; 1986 Nov; 239(2):454-9. PubMed ID: 2430093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenelzine-induced convulsions and alterations in the conversion of 5-HTP-14C to serotonin-14C in vivo.
    Feldstein A; Sidel CM
    Biochem Pharmacol; 1966 Jan; 15(1):111-7. PubMed ID: 5296089
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):31-40. PubMed ID: 1715593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
    Saner A; Pletscher A
    J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
    [No Abstract]   [Full Text] [Related]  

  • 40. Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system.
    Johnson M; Hanson GR; Gibb JW
    Neuropharmacology; 1991 Jun; 30(6):617-22. PubMed ID: 1717871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.